1. Home
  2. AUPH vs DRD Comparison

AUPH vs DRD Comparison

Compare AUPH & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • DRD
  • Stock Information
  • Founded
  • AUPH 1993
  • DRD 1895
  • Country
  • AUPH Canada
  • DRD South Africa
  • Employees
  • AUPH N/A
  • DRD N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • DRD Precious Metals
  • Sector
  • AUPH Health Care
  • DRD Basic Materials
  • Exchange
  • AUPH Nasdaq
  • DRD Nasdaq
  • Market Cap
  • AUPH 1.4B
  • DRD 1.6B
  • IPO Year
  • AUPH 1999
  • DRD N/A
  • Fundamental
  • Price
  • AUPH $12.81
  • DRD $23.33
  • Analyst Decision
  • AUPH Strong Buy
  • DRD Strong Buy
  • Analyst Count
  • AUPH 3
  • DRD 1
  • Target Price
  • AUPH $12.00
  • DRD $18.75
  • AVG Volume (30 Days)
  • AUPH 1.6M
  • DRD 768.8K
  • Earning Date
  • AUPH 11-06-2025
  • DRD 01-01-0001
  • Dividend Yield
  • AUPH N/A
  • DRD 1.97%
  • EPS Growth
  • AUPH N/A
  • DRD 68.66
  • EPS
  • AUPH 0.42
  • DRD 1.46
  • Revenue
  • AUPH $260,111,000.00
  • DRD $443,674,785.00
  • Revenue This Year
  • AUPH $16.92
  • DRD $6.65
  • Revenue Next Year
  • AUPH $14.43
  • DRD $20.77
  • P/E Ratio
  • AUPH $30.61
  • DRD $15.38
  • Revenue Growth
  • AUPH 25.59
  • DRD 26.26
  • 52 Week Low
  • AUPH $6.43
  • DRD $8.38
  • 52 Week High
  • AUPH $12.90
  • DRD $23.36
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 68.86
  • DRD 80.41
  • Support Level
  • AUPH $12.06
  • DRD $17.60
  • Resistance Level
  • AUPH $12.82
  • DRD $23.00
  • Average True Range (ATR)
  • AUPH 0.37
  • DRD 0.71
  • MACD
  • AUPH -0.04
  • DRD 0.31
  • Stochastic Oscillator
  • AUPH 93.23
  • DRD 99.08

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

Share on Social Networks: